Cencora (COR) closed at $340.93 on Oct 16, 2026, down 0.1% on the day. The stock is up 10.2% over the past month, up 12.2% over three months, up 0.9% year to date and up 6.7% over the past year. It trades 9.7% below its 52-week high of $377.54 and 39.3% above its 52-week low of $244.82. The close sits above its 50-day moving average ($320.19) and above its 200-day moving average ($317.46).
NextPick tracks COR in its Health Insurers & Services basket alongside UNH, MCK, CVS, ELV and CI. As of Oct 16, 2026, the basket's money-flow score is 21 (weak inflow), and the basket is up 5.0% over five sessions. Over the past month COR ranks 3rd of 10 basket members by price change.
Yes — the Oct 16, 2026 close of $340.93 is 7.4% above the 200-day average of $317.46.
COR closed 9.7% below its 52-week high of $377.54.
NextPick groups COR with UNH, MCK, CVS, ELV and CI in its Health Insurers & Services basket.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
